85 related articles for article (PubMed ID: 32606921)
1. Erratum: CIRP Regulates BEV-Induced Cell Migration in Gliomas [Corrigendum].
Cancer Manag Res; 2020; 12():4251-4252. PubMed ID: 32606921
[TBL] [Abstract][Full Text] [Related]
2. CIRP regulates BEV-induced cell migration in gliomas.
Liu YX; Zhou JN; Liu KH; Fu XP; Zhang ZW; Zhang QH; Yue W
Cancer Manag Res; 2019; 11():2015-2025. PubMed ID: 30881126
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Circular RNA Profiling Reveals That circRNA_104433 Regulates Cell Growth by Targeting miR-497-5p in Gastric Cancer [Corrigendum].
Cancer Manag Res; 2020; 12():9721-9724. PubMed ID: 33116831
[TBL] [Abstract][Full Text] [Related]
4. Erratum: LncRNA TP73-AS1 Activates TGF-β1 to Promote the Migration and Invasion of Colorectal Cancer Cell [Corrigendum].
Cancer Manag Res; 2020; 12():1799. PubMed ID: 32210621
[TBL] [Abstract][Full Text] [Related]
5. Erratum: NECTIN4 Promotes Papillary Thyroid Cancer Cell Proliferation, Migration, and Invasion and Triggers EMT by Activating AKT [Corrigendum].
Cancer Manag Res; 2019; 11():10041. PubMed ID: 31819636
[TBL] [Abstract][Full Text] [Related]
6. Erratum: The lncRNA HOXA11-AS Regulates Rab3D Expression by Sponging miR-125a-5p Promoting Metastasis of Osteosarcoma [Corrigendum].
Cancer Manag Res; 2021; 13():9351-9353. PubMed ID: 34992460
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Stanniocalcin 2 (STC2) Expression Promotes Post-Radiation Survival, Migration and Invasion of Nasopharyngeal Carcinoma Cells [Corrigendum].
Cancer Manag Res; 2019; 11():10409. PubMed ID: 31853197
[TBL] [Abstract][Full Text] [Related]
8. Erratum: lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells [Corrigendum].
Cancer Manag Res; 2020; 12():8055. PubMed ID: 32982403
[TBL] [Abstract][Full Text] [Related]
9. Erratum: The Blood Biomarkers of Thyroid Cancer [Corrigendum].
Cancer Manag Res; 2022; 14():49-50. PubMed ID: 35023970
[TBL] [Abstract][Full Text] [Related]
10. Erratum: KLF7 Promotes Gastric Carcinogenesis Through Regulation of ANTXR1 [Corrigendum].
Cancer Manag Res; 2021; 13():6113. PubMed ID: 34377029
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum].
Cancer Manag Res; 2021; 13():7055-7056. PubMed ID: 34531683
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum].
Cancer Manag Res; 2021; 13():6797-6798. PubMed ID: 34512019
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum].
Cancer Manag Res; 2020; 12():4169-4170. PubMed ID: 32581588
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():4967. PubMed ID: 34188549
[TBL] [Abstract][Full Text] [Related]
15. Erratum: A Sensitive PCR-Based Method for Somatic Mutations Enrichment and Screening [Corrigendum].
Cancer Manag Res; 2021; 13():9025-9026. PubMed ID: 34916845
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum].
Cancer Manag Res; 2021; 13():8525-8526. PubMed ID: 34849021
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum].
Cancer Manag Res; 2021; 13():8353-8354. PubMed ID: 34795522
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer [Corrigendum].
Cancer Manag Res; 2020; 12():4957. PubMed ID: 32617018
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum].
Cancer Manag Res; 2022; 14():409-410. PubMed ID: 35140518
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum].
Cancer Manag Res; 2021; 13():2515. PubMed ID: 33776476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
